tiprankstipranks

Matthew Callahan Insider Profile

4 Followers
Matthew Callahan, Director at Orthocell Ltd, holds 74.59M shares in Botanix Pharmaceuticals Limited (Ticker: AU:BOT), holds 19.66M shares in Emyria Ltd (Ticker: AU:EMD), holds 1.66M shares in Orthocell Ltd (Ticker: AU:OCC).
tipranks
Matthew  Callahan

Matthew Callahan
Orthocell Ltd (OCC)
Director

Ranked #21,398 out of 98,743 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+14.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$22M
93.14%
4.12%
2.74%
A breakdown of Matthew Callahan's holdings

Insider Roles

Botanix Pharmaceuticals Limited
(BOT)
Executive
Emyria Ltd
(EMD)
Director
Orthocell Ltd
(OCC)
Director
Roles that Matthew Callahan holds in companies

Most Profitable Insider Trade

Stock:
Botanix Pharmaceuticals Limited
(BOT)
Rating:Informative Buy
Date:Dec 14, 2022 - Dec 14, 2023
Return:+150.00%
The most profitable trade made by Matthew Callahan

Matthew Callahan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Orthocell Ltd
Jan 29, 2021
Director
Uninformative Sell
AU$613.76K
Botanix Pharmaceuticals Limited
May 22, 2023
Executive
Uninformative Buy
AU$20.88M
Emyria Ltd
Feb 23, 2023
Director
Informative Buy
10.00K
AU$923.81K
List of latest transactions for each holding click on a transaction to see Matthew Callahan's performance on stock

Matthew Callahan insider profile FAQ

What is the percentage of profitable transactions made by Matthew Callahan?
The percentage of profitable transactions made by Matthew Callahan is 40%.
    What is the average return per transaction made by Matthew Callahan?
    The average return per transaction made by Matthew Callahan is 14.20%.
      What stocks does Matthew Callahan hold?
      Matthew Callahan holds: AU:OCC, AU:BOT, AU:EMD stocks.
        What was Matthew Callahan’s latest transaction?
        Matthew Callahan latest transaction was an Uninformative Buy of ―.
          What was Matthew Callahan's most profitable transaction?
          Matthew Callahan’s most profitable transaction was an Informative Buy of AU:BOT stock on December 14, 2022. The return on the trade was 150.00%.
            What is Matthew Callahan's role in Orthocell Ltd?
            Matthew Callahan's role in Orthocell Ltd is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.